Type 1 Diabetes is one of the most common chronic, life-long diseases globally, and it is most often diagnosed in children, adolescents and young adults.
The disease is caused by the destruction of the insulin-producing beta cells in the pancreas and requires continuous daily treatment with exogenous insulin injections. It is associated with an increased risk for long-term complications decreasing the quality of life and average life-expectancy. Around 15 million people are affected by this disease worldwide, and its incidence is rapidly increasing all over the world. There is no curative treatment available and therefore the prevention of the disease is a major goal of ongoing research efforts.